State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us.
State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us.
复制标题
DOI:
10.3389/fnagi.2022.971007
复制
发表时间:
2022
影响因子:
4.8
通讯作者:
中科院分区:
文献类型:
--
作者:
The menopause is a midlife endocrinological process that greatly affects women’s central nervous system functions. Over the last 2 decades numerous clinical studies have addressed the influence of ovarian hormone decline on neurological disorders like Parkinson’s disease and Alzheimer’s disease. However, the findings in support of a role for age at menopause, type of menopause and hormone replacement therapy on Parkinson’s disease onset and its core features show inconsistencies due to the heterogeneity in the study design. Here, we provide a unified overview of the clinical literature on the influence of menopause and ovarian hormones on Parkinson’s disease. We highlight the possible sources of conflicting evidence and gather considerations for future observational clinical studies that aim to explore the neurological impact of menopause-related features in Parkinson’s disease.
登录
查看更多内容
影响因子:
4.3
作者:
Diotel N;Charlier TD;Lefebvre d'Hellencourt C;Couret D;Trudeau VL;Nicolau JC;Meilhac O;Kah O;Pellegrini E
通讯作者:
Pellegrini E
影响因子:
2.5
作者:
Almey A;Milner TA;Brake WG
通讯作者:
Brake WG
影响因子:
2.1
作者:
Domchek, Susan M.;Rebbeck, Timothy R.
通讯作者:
Rebbeck, Timothy R.
影响因子:
9.9
作者:
Ascherio, A;Chen, H;Speizer, FE
通讯作者:
Speizer, FE
DOI:
10.1111/j.1471-0528.2005.00696.x
发表时间:
2005-07-01
影响因子:
5.8
作者:
Farquhar, CM;Sadler, L;Stewart, AW
通讯作者:
Stewart, AW